SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-20-030660
Filing Date
2020-10-08
Accepted
2020-10-08 16:57:18
Documents
4
Period of Report
2020-10-05
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 5.01: Changes in Control of Registrant
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea127966-8k_inspyrtherap.htm 8-K 41004
2 ea127966ex3-01i_inspyrtherap.htm EX-3.01(I) 67392
3 TERMINATION AGREEMENT ea127966ex10-01_inspyrtherap.htm EX-10.01 33469
4 PRESS RELEASE DATED OCTOBER 8, 2020 ea127966ex99-01_inspyrtherap.htm EX-99.01 5808
  Complete submission text file 0001213900-20-030660.txt   149129
Mailing Address 2629 TOWNSGATE RD, SUITE 215 WESTLAKE VILLAGE CA 91361
Business Address 2629 TOWNSGATE RD, SUITE 215 WESTLAKE VILLAGE CA 91361 (210) 479-8112
Inspyr Therapeutics, Inc. (Filer) CIK: 0001421204 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-55331 | Film No.: 201231405
SIC: 2834 Pharmaceutical Preparations